Literature DB >> 8176554

Efficacy of the Flutter device for airway mucus clearance in patients with cystic fibrosis.

M W Konstan1, R C Stern, C F Doershuk.   

Abstract

The Flutter is a handheld device designed to facilitate clearance of mucus in hypersecretory lung disorders. Exhalation through the Flutter results in oscillations of expiratory pressure and airflow, which vibrate the airway walls (loosening mucus), decrease the collapsibility of the airways, and accelerate airflow, facilitating movement of mucus up the airways. We studied 18 patients with cystic fibrosis and mild to moderate lung disease to determine the efficacy of the Flutter in clearing mucus from the airways. The amount of sputum expectorated (measured by weight) when the Flutter was used was compared with the amount expectorated with vigorous voluntary coughing and with postural drainage (chest percussion and vibration). The amount of sputum expectorated by subjects using the Flutter was more than three times the amount expectorated with either voluntary cough or postural drainage (p < 0.001). There were no adverse effects. The Flutter is simple to use, inexpensive, and fully portable, and once the patient and family are instructed in its use, it does not require the assistance of a caregiver. For hospitalized patients, elimination of the need for a therapist could reduce health care costs. Long-term studies of the use of the Flutter seem justified to determine its effects on pulmonary function and outcome.

Entities:  

Mesh:

Year:  1994        PMID: 8176554     DOI: 10.1016/s0022-3476(05)81356-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  25 in total

Review 1.  Physiotherapy in cystic fibrosis.

Authors:  S A Prasad; E L Tannenbaum; C Mikelsons
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

2.  Oscillating devices for airway clearance in people with cystic fibrosis.

Authors:  Lisa Morrison; Stephanie Milroy
Journal:  Cochrane Database Syst Rev       Date:  2020-04-30

3.  Oscillatory positive expiratory pressure treatment in lower respiratory tract infection.

Authors:  Yingmeng Ni; Lin Ding; Youchao Yu; Ranran Dai; Hong Chen; Guochao Shi
Journal:  Exp Ther Med       Date:  2018-08-01       Impact factor: 2.447

Review 4.  New and emerging therapies for pulmonary complications of cystic fibrosis.

Authors:  M R Tonelli; M L Aitken
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  Lessons learned from a randomized trial of airway secretion clearance techniques in cystic fibrosis.

Authors:  Marci K Sontag; Alexandra L Quittner; Avani C Modi; Joni M Koenig; Don Giles; Christopher M Oermann; Michael W Konstan; Robert Castile; Frank J Accurso
Journal:  Pediatr Pulmonol       Date:  2010-03

Review 6.  Cystic fibrosis lung disease: genetic influences, microbial interactions, and radiological assessment.

Authors:  Samuel M Moskowitz; Ronald L Gibson; Eric L Effmann
Journal:  Pediatr Radiol       Date:  2005-05-03

Review 7.  Oscillating devices for airway clearance in people with cystic fibrosis.

Authors:  Lisa Morrison; Stephanie Innes
Journal:  Cochrane Database Syst Rev       Date:  2017-05-04

8.  Airway clearance devices for cystic fibrosis: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-11-01

9.  The Efficacy of Flutter® and Active Cycle of Breathing Techniques in Patients with Bronchiectasis: A Prospective, Randomized, Comparative Study.

Authors:  Bilge Üzmezoğlu; Gündeniz Altıay; Levent Özdemir; Hakan Tuna; Necdet Süt
Journal:  Turk Thorac J       Date:  2018-06-12

Review 10.  Drug management of noninfective complications of cystic fibrosis.

Authors:  I Sanchez; E Guiraldes
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.